» Articles » PMID: 20164426

CC Chemokine Ligand 3 Overcomes the Bacteriocidal and Phagocytic Defect of Macrophages and Hastens Recovery from Experimental Otitis Media in TNF-/- Mice

Overview
Journal J Immunol
Date 2010 Feb 19
PMID 20164426
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Innate immune mechanisms are crucial in defense against bacterial illnesses in humans, as evidenced by abnormal antibacterial responses due to defects in TLR signaling, seen in children with MyD88 or IL-1R-associated kinase 4 deficiency. Otitis media (OM) is the most common disease of childhood, and the role of innate immune molecules in this disorder remains unclear. In a murine model of OM, we show that, in the absence of TNF, a key effector of innate immunity, this disease is prolonged after middle ear infection with nontypeable Haemophilus influenzae (NTHi). In the absence of TNF, mice fail to upregulate both TLRs and downstream genes and proteins, such as CCL3, resulting in defects in both inflammatory cell recruitment and macrophage function. Peritoneal macrophages of mice lacking TNF have a diminished ability to phagocytose and kill NTHi, and this defect is partially corrected in vitro by exogenous rTNF. Addition of rCCL3 alone or in combination with rTNF restores phagocytosis and killing by TNF-deficient macrophages to that of unstimulated wild-type macrophages. In vivo administration of rCCL3 to animals deficient in TNF fully restores the ability to control OM due to NTHi, whereas a CCL3-blocking Ab impaired the ability of wild-type mice to recover from OM. Thus, CCL3 is a potent downstream effector of TNF-mediated inflammation in vitro and in vivo. Manipulation of CCL3 and/or TNF may prove to be effective therapeutic approaches in OM or other conditions associated with defective TNF generation.

Citing Articles

1,8-Cineol Attenuates Checkpoint Molecule PDL-1 and Adhesion Molecule CX3CR1 in Circulating Monocytes in Otitis Media Patients.

Leichtle A, Jeschke S, Plotze-Martin K, Idel C, Bruchhage K, Pries R J Pers Med. 2024; 14(3).

PMID: 38541021 PMC: 10971202. DOI: 10.3390/jpm14030279.


Immunomodulatory Response of the Middle Ear Epithelial Cells in Otitis Media.

Leffers D, Penxova Z, Kempin T, Darr M, Fleckner J, Hollfelder D Otol Neurotol. 2024; 45(3):e248-e255.

PMID: 38238924 PMC: 10922874. DOI: 10.1097/MAO.0000000000004096.


Immunomodulation as a Protective Strategy in Chronic Otitis Media.

Leichtle A, Kurabi A, Leffers D, Darr M, Draf C, Ryan A Front Cell Infect Microbiol. 2022; 12:826192.

PMID: 35433505 PMC: 9005906. DOI: 10.3389/fcimb.2022.826192.


HB-EGF Plays a Pivotal Role in Mucosal Hyperplasia During Otitis Media Induced by a Viral Analog.

Sakamoto T, Pak K, Chavez E, Ryan A, Kurabi A Front Cell Infect Microbiol. 2022; 12:823714.

PMID: 35281434 PMC: 8904902. DOI: 10.3389/fcimb.2022.823714.


Leukotriene B4 Is a Major Determinant of Leukocyte Recruitment During Otitis Media.

Heo K, Pak K, Kurabi A, Ryan A Front Cell Infect Microbiol. 2022; 11:768815.

PMID: 35004347 PMC: 8727869. DOI: 10.3389/fcimb.2021.768815.


References
1.
Wiertsema S, Khoo S, Baynam G, Veenhoven R, Laing I, Zielhuis G . Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin Vaccine Immunol. 2006; 13(8):892-7. PMC: 1539116. DOI: 10.1128/CVI.00100-06. View

2.
Karalus R, Murphy T . Purification and characterization of outer membrane protein P6, a vaccine antigen of non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol. 1999; 26(2):159-66. DOI: 10.1111/j.1574-695X.1999.tb01384.x. View

3.
Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

4.
Xu Y, Hunt N, Bao S . The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Immunol Cell Biol. 2007; 85(8):633-9. DOI: 10.1038/sj.icb.7100112. View

5.
von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku C . Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 2008; 321(5889):691-6. PMC: 2688396. DOI: 10.1126/science.1158298. View